Comment on: Efficacy of intracameral moxifloxacin in prevention of post-cataract surgery endophthalmitis: a randomized controlled trial

Aravind Haripriya, David F. Chang

Open source

DOI
10.1097/j.jcrs.0000000000001830
Published
2026-01
Container
Journal of Cataract & Refractive Surgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/j.jcrs.0000000000001830,
  title = {Comment on: Efficacy of intracameral moxifloxacin in prevention of post-cataract surgery endophthalmitis: a randomized controlled trial},
  author = {Aravind Haripriya and David F. Chang},
  year = {2026},
  journal = {Journal of Cataract \& Refractive Surgery},
  doi = {10.1097/j.jcrs.0000000000001830},
  url = {https://doi.org/10.1097/j.jcrs.0000000000001830}
}

RIS

TY  - JOUR
TI  - Comment on: Efficacy of intracameral moxifloxacin in prevention of post-cataract surgery endophthalmitis: a randomized controlled trial
AU  - Aravind Haripriya
AU  - David F. Chang
PY  - 2026
JO  - Journal of Cataract & Refractive Surgery
DO  - 10.1097/j.jcrs.0000000000001830
UR  - https://doi.org/10.1097/j.jcrs.0000000000001830
ER  - 

APA

Haripriya, A., & Chang, D. F. (2026). Comment on: Efficacy of intracameral moxifloxacin in prevention of post-cataract surgery endophthalmitis: a randomized controlled trial. Journal of Cataract & Refractive Surgery. https://doi.org/10.1097/j.jcrs.0000000000001830

Source records